CIANCETTA, Antonella
 Distribuzione geografica
Continente #
NA - Nord America 1.505
AS - Asia 590
EU - Europa 411
SA - Sud America 95
AF - Africa 4
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.609
Nazione #
US - Stati Uniti d'America 1.491
SG - Singapore 371
IT - Italia 156
CN - Cina 91
BR - Brasile 85
DE - Germania 59
TR - Turchia 52
UA - Ucraina 45
GB - Regno Unito 39
PL - Polonia 39
HK - Hong Kong 26
SE - Svezia 24
ID - Indonesia 19
FI - Finlandia 18
CA - Canada 12
CZ - Repubblica Ceca 8
AT - Austria 6
NL - Olanda 6
PK - Pakistan 6
BE - Belgio 5
UZ - Uzbekistan 5
AR - Argentina 4
KR - Corea 4
ZA - Sudafrica 4
BD - Bangladesh 3
PH - Filippine 3
RU - Federazione Russa 3
AU - Australia 2
CL - Cile 2
IN - India 2
LT - Lituania 2
AM - Armenia 1
CO - Colombia 1
EC - Ecuador 1
EU - Europa 1
FR - Francia 1
IQ - Iraq 1
IR - Iran 1
JP - Giappone 1
KW - Kuwait 1
LB - Libano 1
MX - Messico 1
NZ - Nuova Zelanda 1
PA - Panama 1
PY - Paraguay 1
TW - Taiwan 1
VE - Venezuela 1
VN - Vietnam 1
Totale 2.609
Città #
Santa Clara 182
Singapore 149
Chandler 138
Fairfield 138
Ashburn 120
Ann Arbor 93
Houston 91
Woodbridge 85
Ferrara 78
Jacksonville 54
Wilmington 50
Seattle 49
Princeton 46
Cambridge 44
Warsaw 39
Hong Kong 26
Izmir 25
Shanghai 24
Jakarta 19
San Diego 18
Los Angeles 15
London 13
Beijing 12
Milan 12
Washington 12
Nanjing 11
Nuremberg 11
Boardman 9
Bologna 9
Falls Church 9
Brno 8
Helsinki 8
New York 8
Toronto 7
Changsha 6
Chicago 6
Brussels 5
Council Bluffs 5
Padova 5
Redmond 5
Tashkent 5
Ferrara di Monte Baldo 4
Norwalk 4
San Giorgio delle Pertiche 4
São Paulo 4
Addison 3
Chiswick 3
Falkenstein 3
Goiânia 3
Jiaxing 3
Jinan 3
Lahore 3
Manila 3
Phoenix 3
San Francisco 3
Secaucus 3
Stockholm 3
The Dalles 3
Zhengzhou 3
Assago 2
Bari 2
Belo Horizonte 2
Boston 2
Brasília 2
Bremen 2
Curitiba 2
Gangnam-gu 2
Hebei 2
Jaboatão dos Guararapes 2
Kilburn 2
Kunming 2
Molinella 2
Munich 2
Nanchang 2
Naples 2
Novara 2
Osasco 2
Parma 2
Praia Grande 2
Ribeirão Preto 2
San Jose 2
Tianjin 2
Venice 2
Vienna 2
Yeongdeungpo-gu 2
Andaraí 1
Andradina 1
Araraquara 1
Arroio Grande 1
Asunción 1
Atlanta 1
Baghdad 1
Bauru 1
Benito Juarez 1
Betim 1
Bragado 1
Brentford 1
Buenos Aires 1
Cabo Frio 1
Calgary 1
Totale 1.774
Nome #
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 177
5,7-Disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazines as pharmacological tools to explore the antagonist selectivity profiles toward adenosine receptors 169
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation 150
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and Structurally Simplified Analogs. Chemistry and SAR Profile as Adenosine Receptor Antagonists 139
The influence of the 1-(3-Trifluoromethyl-Benzyl)-1H-Pyrazole-4-yl moiety on the adenosine receptors affinity profile of pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c] pyrimidine derivatives 132
null 118
Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor 108
7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: Structural investigations at the 5-position to target human A(1) and A(2A) adenosine receptors. Molecular modeling and pharmacological studies 100
null 90
Novel Aryl Sulfonamide Derivatives as NLRP3 Inflammasome Inhibitors for the Potential Treatment of Cancer 71
A 2a adenosine receptor: Structures, modeling, and medicinal chemistry 71
Revisiting a receptor-based pharmacophore hypothesis for human A(2A) adenosine receptor antagonists 60
Bridging molecular docking to membrane molecular dynamics to investigate GPCR-ligand recognition: The human A2A adenosine receptor as a key study 51
A QM/MM study of the binding of RAPTA ligands to cathepsin B 51
A3 adenosine receptor activation mechanisms: molecular dynamics analysis of inactive, active, and fully active states 50
Demystifying P2Y1 Receptor Ligand Recognition through Docking and Molecular Dynamics Analyses 47
DockBench: An Integrated Informatic Platform Bridging the Gap between the Robust Validation of Docking Protocols and Virtual Screening Simulations 44
Deciphering the Complexity of Ligand-Protein Recognition Pathways Using Supervised Molecular Dynamics (SuMD) Simulations 42
Probe Confined Dynamic Mapping for G Protein-Coupled Receptor Allosteric Site Prediction 41
Enhancing Ligand and Protein Sampling Using Sequential Monte Carlo 41
Aquaporin inhibition by gold(III) compounds: New insights 39
Conjugates between minor groove binders and Zn(II)-tach complexes: Synthesis, characterization, and interaction with plasmid DNA 38
Activation of carboplatin by chloride ions: a theoretical investigation 37
Activation of carboplatin by carbonate: A theoretical investigation 37
Advances in Computational Techniques to Study GPCR-Ligand Recognition 37
Design and in Vivo Characterization of A 1 Adenosine Receptor Agonists in the Native Ribose and Conformationally Constrained (N)-Methanocarba Series 37
Alternative quality assessment strategy to compare performances of GPCR-ligand docking protocols: the human adenosine A(2A) receptor as a case study 35
South (S)- and north (N)-methanocarba-7-deazaadenosine analogues as inhibitors of human adenosine kinase 33
Bitopic fluorescent antagonists of the A2A adenosine receptor based on pyrazolo[4,3-: E] [1,2,4]triazolo[1,5- c] pyrimidin-5-amine functionalized congeners 32
Near-Complete Response to Osimertinib for Advanced Non-Small-Cell Lung Cancer in a Pretreated Patient Bearing Rare Compound Exon 20 Mutation (S768I + V774M): A Case Report 32
Rationalization of the inhibition activity of structurally related organometallic compounds against the drug target cathepsin B by DFT 31
Sensitivity of Binding Free Energy Calculations to Initial Protein Crystal Structure 30
Pyrimidine nucleotides containing a (S)-methanocarba ring as P2Y6 receptor agonists 29
New Trends in Inspecting GPCR-ligand Recognition Process: the Contribution of the Molecular Modeling Section (MMS) at the University of Padova 28
Exploring the recognition pathway at the human A2A adenosine receptor of the endogenous agonist adenosine using supervised molecular dynamics simulations 27
Understanding allosteric interactions in G protein-coupled receptors using Supervised Molecular Dynamics: A prototype study analysing the human A3 adenosine receptor positive allosteric modulator LUF6000 27
Repurposing of a nucleoside scaffold from adenosine receptor agonists to opioid receptor antagonists 27
Structure-Based Scaffold Repurposing for G Protein-Coupled Receptors: Transformation of Adenosine Derivatives into 5HT2B/5HT2C Serotonin Receptor Antagonists 26
Structure-Based Design of 3-(4-Aryl-1H-1,2,3-Triazol-1-yl)-Biphenyl Derivatives as P2Y14 Receptor Antagonists 25
Targeting Aquaporin Function: Potent Inhibition of Aquaglyceroporin-3 by a Gold-Based Compound 25
Design and synthesis of 1,4,8-triazaspiro[4.5]decan-2-one derivatives as novel mitochondrial permeability transition pore inhibitors 24
Structure activity relationship of 2-arylalkynyl-adenine derivatives as human A3 adenosine receptor antagonists 24
Structure-Guided Modification of Heterocyclic Antagonists of the P2Y 14 Receptor 23
A Multi-Angle Approach to Predict Peptide-GPCR Complexes: The N/OFQ-NOP System as a Successful AlphaFold Application Case Study 22
Perturbation of fluid dynamics properties of water molecules during G protein-coupled receptor-ligand recognition: the human A2A adenosine receptor as a key study 21
Polypharmacology of conformationally locked methanocarba nucleosides 21
Advances in GPCR modeling evaluated by the GPCR Dock 2013 assessment: Meeting new challenges 20
Structural probing and molecular modeling of the A3 adenosine receptor: A focus on agonist binding 20
Synthesis and Spectroscopic Characterisation of a Heterodinuclear Iron(III)-Copper(II) Complex Based on an Asymmetric Dinucleating Ligand System 20
Influence of key amino acid mutation on the active site structure and on folding in acetyl-CoA synthase: A theoretical perspective 19
Breakthrough in GPCR Crystallography and Its Impact on Computer-Aided Drug Design 18
Purine (N)-Methanocarba Nucleoside Derivatives Lacking an Exocyclic Amine as Selective A3 Adenosine Receptor Agonists 18
Implementing the “Best Template Searching” tool into Adenosiland platform 16
In silico 3D modeling of binding activities 16
HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS 15
Probing non-peptide agonists binding at the human nociceptin/orphanin FQ receptor: a molecular modelling study 14
Supramolecular delivery systems for polyphenols: A green approach to predict in vivo permeability through an in vitro setup 13
Enhancing torsional sampling using fully adaptive simulated tempering 13
The path to the G protein-coupled receptor structural landscape: Major milestones and future directions 10
“Protein-ligand docking: virtual screening and applications to drug discovery” 8
Journal of Medicinal Chemistry Collection: Drug Discovery in Italy 5
[1,2,4]triazolo[1,5-c]pyrimidines as A(3) adenosine receptor antagonists 4
Hidden GPCR structural transitions addressed by multiple walker supervised molecular dynamics (mwSuMD) 1
Inspecting receptor-ligand interaction using molecular dynamics simulations: new insights from Adenosiland 1
P2Y14 Receptor 1
Totale 2.751
Categoria #
all - tutte 26.242
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.228
Totale 27.470


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202018 0 0 0 0 0 0 0 0 0 0 9 9
2020/2021221 13 7 15 20 7 24 7 25 16 45 32 10
2021/2022366 2 16 6 100 16 5 18 61 20 7 13 102
2022/2023313 51 22 24 21 40 26 8 44 47 9 13 8
2023/2024271 16 25 27 12 28 48 14 24 7 4 4 62
2024/20251.004 19 21 98 23 137 100 38 64 229 172 103 0
Totale 2.751